A - Human Necessities – 61 – B
Patent
A - Human Necessities
61
B
A61B 5/00 (2006.01) G06Q 50/22 (2012.01) G01N 33/15 (2006.01)
Patent
CA 2540223
The ADVERSE DRUG REACTION EARLY WARNING SYSTEM (DREW) alerts pharmaceutical companies of potentially dangerous side effects before they manifest. DREW uses biomarkers in blood and urine as well as symptoms gathered from patients taking a particular medication. It analyses and interprets this data to detect deviations from normal biological values. If found, deviations are applied to a computerized grid of early warning biomarkers to trace a pattern of developing side effects. The alerted pharmaceutical company can now take preventive action. Thus, DREW is a definite innovation from existing adverse effect surveillance systems which are activated by reported side effects. DREW attempts to prevent the manifestation of full blown side effects before they occur. The system is implemented by a network of participating physicians strategically positioned in areas where the particular medication is used. DREW will make drugs safer for patients and limit liability from adverse effect consequences.
Ben-Oliel Susan M.
Sperer Ben
LandOfFree
Drug reaction early warning system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug reaction early warning system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug reaction early warning system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952100